Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1979 Mar;76(3):1288–1292. doi: 10.1073/pnas.76.3.1288

Human melanoma cells have both nerve growth factor and nerve growth factor-specific receptors on their cell surfaces.

S A Sherwin, A H Sliski, G J Todaro
PMCID: PMC383236  PMID: 375235

Abstract

Human melanoma cells were examined in an indirect membrane immunofluorescence assay for surface nerve growth factor (NGF) and NGF receptors. This assay revealed that human melanoma cells have various levels of NGF and NGF receptors on the plasma membrane, whereas a variety of human sarcoma and carcinoma tumor cells and normal human fibroblasts are negative. Surface NGF could be detected on melanoma cells with a rabbit antiserum directed to NGF at titers as high as 1:64; prior adsorption of this antibody with mouse 2.5S NGF resulted in a loss of fluorescence. The melanoma cells were positive whether or not they were grown in the presence of fetal calf serum. NGF production by human melanomas is a previously unrecognized property of this differentiated cell type. Although other cells in culture have been shown to produce NGF, the association of NGF production with the presence of NGF receptors on the cell surface is rare among tumor cells, and may represent an opportunity for "autostimulation" of melanoma cells by this growth factor.

Full text

PDF
1288

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaronson S. A., Todaro G. J., Freeman A. E. Human sarcoma cells in culture. Identification by colony-forming ability on monolayers of normal cells. Exp Cell Res. 1970 Jul;61(1):1–5. doi: 10.1016/0014-4827(70)90250-8. [DOI] [PubMed] [Google Scholar]
  2. Berger E. A., Shooter E. M. Evidence for pro-beta-nerve growth factor, a biosynthetic precursor to beta-nerve growth factor. Proc Natl Acad Sci U S A. 1977 Sep;74(9):3647–3651. doi: 10.1073/pnas.74.9.3647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bocchini V., Angeletti P. U. The nerve growth factor: purification as a 30,000-molecular-weight protein. Proc Natl Acad Sci U S A. 1969 Oct;64(2):787–794. doi: 10.1073/pnas.64.2.787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bradshaw R., Young M. Nerve growth factor-recent developments and perspectives. Biochem Pharmacol. 1976 Jul 1;25(13):1445–1449. doi: 10.1016/0006-2952(76)90058-7. [DOI] [PubMed] [Google Scholar]
  5. Bystryn J. C., Smalley J. R. Identification and solubilization of iodinated cell surface human melanoma associated antigens. Int J Cancer. 1977 Aug 15;20(2):165–172. doi: 10.1002/ijc.2910200202. [DOI] [PubMed] [Google Scholar]
  6. Campenot R. B. Local control of neurite development by nerve growth factor. Proc Natl Acad Sci U S A. 1977 Oct;74(10):4516–4519. doi: 10.1073/pnas.74.10.4516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Carey T. E., Takahashi T., Resnick L. A., Oettgen H. F., Old L. J. Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. Proc Natl Acad Sci U S A. 1976 Sep;73(9):3278–3282. doi: 10.1073/pnas.73.9.3278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chamley J. H., Dowel J. J. Specificity of nerve fibre 'attraction' to autonomic effector organs in tissue culture. Exp Cell Res. 1975 Jan;90(1):1–7. doi: 10.1016/0014-4827(75)90349-3. [DOI] [PubMed] [Google Scholar]
  9. De Larco J. E., Tadaro G. J. A human fibrosarcoma cell line producing multiplication stimulating activity (MSA)-related peptides. Nature. 1978 Mar 23;272(5651):356–358. doi: 10.1038/272356a0. [DOI] [PubMed] [Google Scholar]
  10. DeLarco J., Todaro G. J. Membrane receptors for murine leukemia viruses: characterization using the purified viral envelope glycoprotein, gp71. Cell. 1976 Jul;8(3):365–371. doi: 10.1016/0092-8674(76)90148-3. [DOI] [PubMed] [Google Scholar]
  11. Fabricant R. N., De Larco J. E., Todaro G. J. Nerve growth factor receptors on human melanoma cells in culture. Proc Natl Acad Sci U S A. 1977 Feb;74(2):565–569. doi: 10.1073/pnas.74.2.565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Giard D. J., Aaronson S. A., Todaro G. J., Arnstein P., Kersey J. H., Dosik H., Parks W. P. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst. 1973 Nov;51(5):1417–1423. doi: 10.1093/jnci/51.5.1417. [DOI] [PubMed] [Google Scholar]
  13. Goldstein L. D., Reynolds C. P., Perez-Polo J. R. Isolation of human nerve growth factor from placental tissue. Neurochem Res. 1978 Apr;3(2):175–183. doi: 10.1007/BF00964058. [DOI] [PubMed] [Google Scholar]
  14. Greene L. A. Nerve growth factor prevents the death and stimulates the neuronal differentiation of clonal PC12 pheochromocytoma cells in serum-free medium. J Cell Biol. 1978 Sep;78(3):747–755. doi: 10.1083/jcb.78.3.747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Harper G. P., Pearce F. L., Vernon C. A. Production of nerve growth factor by the mouse adrenal medulla. Nature. 1976 May 20;261(5557):251–253. doi: 10.1038/261251a0. [DOI] [PubMed] [Google Scholar]
  16. Hellström I., Hellström K. E., van Belle G., Warner G. A. Leukocyte-mediated reactivity to human tumors as detected by the leukocyte adherence inhibition test. I. Demonstration of tumor type-specific reactions. Am J Clin Pathol. 1977 Nov;68(5 Suppl):706–714. [PubMed] [Google Scholar]
  17. LEVI-MONTALCINI R., ANGELETTI P. U. Essential role of the nerve growth factor in the survival and maintenance of dissociated sensory and sympathetic embryonic nerve cells in vitro. Dev Biol. 1963 Mar;6:653–659. doi: 10.1016/0012-1606(63)90149-0. [DOI] [PubMed] [Google Scholar]
  18. Levi-Montalcini R., Angeletti P. U. Nerve growth factor. Physiol Rev. 1968 Jul;48(3):534–569. doi: 10.1152/physrev.1968.48.3.534. [DOI] [PubMed] [Google Scholar]
  19. Lewis M. G. Possible immunological factors in human malignant melanoma in Uganda. Lancet. 1967 Oct 28;2(7522):921–922. doi: 10.1016/s0140-6736(67)90236-x. [DOI] [PubMed] [Google Scholar]
  20. Morton D. L., Malmgren R. A., Holmes E. C., Ketcham A. S. Demonstration of antibodies against human malignant melanoma by immunofluorescence. Surgery. 1968 Jul;64(1):233–240. [PubMed] [Google Scholar]
  21. Murphy R. A., Oger J., Saide J. D., Blanchard M. H., Arnason B. G., Hogan C., Pantazis N. J. Secretion of nerve growth factor by central nervous system glioma cells in culture. J Cell Biol. 1977 Mar;72(3):769–773. doi: 10.1083/jcb.72.3.769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Murphy R. A., Pantazis N. J., Arnason B. G., Young M. Secretion of a nerve growth factor by mouse neuroblastoma cells in culture. Proc Natl Acad Sci U S A. 1975 May;72(5):1895–1898. doi: 10.1073/pnas.72.5.1895. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Oger J., Arnason B. G., Pantazis N., Lehrich J., Young M. Synthesis of nerve growth factor by L and 3T3 cells in culture. Proc Natl Acad Sci U S A. 1974 Apr;71(4):1554–1558. doi: 10.1073/pnas.71.4.1554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Revoltella R., Bertolini L., Pediconi M., Vigneti E. Specific binding of nerve growth factor (NGF) by murine C 1300 neuroblastoma cells. J Exp Med. 1974 Aug 1;140(2):437–451. doi: 10.1084/jem.140.2.437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Roth J. A., Slocum H. K., Pellegrino M. A., Holmes E. C., Reisfeld R. A. Purification of soluble human melanoma-associated antigens. Cancer Res. 1976 Jul;36(7 Pt 1):2360–2364. [PubMed] [Google Scholar]
  26. Shields R. Growth factors for tumours. Nature. 1978 Apr 20;272(5655):670–671. doi: 10.1038/272670a0. [DOI] [PubMed] [Google Scholar]
  27. Shiku H., Takahashi T., Oettgen H. F. Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens. J Exp Med. 1976 Oct 1;144(4):873–881. doi: 10.1084/jem.144.4.873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Stuhlmiller G. M., Green R. W., Seigler H. F. Solubilization and partial isolation of human melanoma tumor-associated antigens. J Natl Cancer Inst. 1978 Jul;61(1):61–67. doi: 10.1093/jnci/61.1.61. [DOI] [PubMed] [Google Scholar]
  29. Unsicker K., Krisch B., Otten U., Thoenen H. Nerve growth factor-induced fiber outgrowth from isolated rat adrenal chromaffin cells: impairment by glucocorticoids. Proc Natl Acad Sci U S A. 1978 Jul;75(7):3498–3502. doi: 10.1073/pnas.75.7.3498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Varon S., Nomura J., Shooter E. M. The isolation of the mouse nerve growth factor protein in a high molecular weight form. Biochemistry. 1967 Jul;6(7):2202–2209. doi: 10.1021/bi00859a043. [DOI] [PubMed] [Google Scholar]
  31. Young M., Oger J., Blanchard M. H., Asdourian H., Amos H., Arnason B. G. Secretion of a nerve growth factor by primary chick fibroblast cultures. Science. 1975 Jan 31;187(4174):361–362. doi: 10.1126/science.1167427. [DOI] [PubMed] [Google Scholar]
  32. de Larco J. E., Todaro G. J. Growth factors from murine sarcoma virus-transformed cells. Proc Natl Acad Sci U S A. 1978 Aug;75(8):4001–4005. doi: 10.1073/pnas.75.8.4001. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES